Research Paper Volume 14, Issue 16 pp 6605—6625

Transcriptomic signature associated with RNA-binding proteins for survival stratification of laryngeal cancer

Yujie Shen1, *, , Huijun Chen2, *, , Qiang Huang1, *, , Huaidong Du1, , Liang Zhou1, ,

  • 1 Department of Otorhinolaryngology Head and Neck Surgery, Eye, Ear, Nose, and Throat Hospital, Fudan University, Shanghai 200031, Shanghai, China
  • 2 Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, Southeast University, Nanjing 210009, Jiangsu, China
* Equal contribution

Received: March 11, 2022       Accepted: August 3, 2022       Published: August 18, 2022      

https://doi.org/10.18632/aging.204234
How to Cite

Copyright: © 2022 Shen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

RNA-binding proteins (RBPs) have been suggested as important prognostic indicators in different human cancers. This study was designed to search the prognostic value of RBPs of laryngeal squamous cell carcinoma (LSCC). Differentially expressed RBPs (DERBPs) were screened via The Cancer Genome Atlas (TCGA). Bioinformatics methods were used to identify prognostic DERBPs. Expression profiling of training cohort were calculated to develop a transcriptomic signature, which was validated by three independent cohorts (TCGA cohort, GSE65858 cohort and GSE27020 cohort). We identified DERBPs and a set of signatures (GTPBP3, KHDRBS3 and RBM38) were confirmed as prognosis-related hub DERBPs in LSCC, which was also tested and verified by bioinformatics method and molecular biology experiment. The role of immune cell infiltration and drug resistance between subgroups was explored. Furthermore, the risk score based on transcriptomic signature was turned out to be an independent prognostic indicator for LSCC. Finally, a nomogram for further clinical application was established. Our study demonstrated that the transcriptomic signature we constructed could serve as a novel therapeutic target and biomarker for LSCC from the perspective of RBPs.

Abbreviations

RBPs: RNA-binding proteins; LSCC: laryngeal squamous cell carcinoma; DERBPs: differentially expressed RBPs; TCGA: The Cancer Genome Atlas; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; LASSO: least absolute shrinkage and selection operator; GEO: Gene Expression Omnibus; NCBI: National Center of Biotechnology Information; NGS: next-generation sequencing; ROC: receiver operating characteristic; CI: confidence intervals.